International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan

drug protocol number
LPS14410
drug sponsor
Sanofi
drug study
Lixisenatide
drug trial site
KKUH
drug status
Terminated
drug phase